Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Human osteoclast culture from peripheral blood monocytes: phenotypic characterization and quantitation of resorption.

Buckley KA, Chan BY, Fraser WD, Gallagher JA.

Methods Mol Med. 2005;107:55-68. No abstract available.

PMID:
15492364
2.
3.

Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC.

J Cell Physiol. 2005 Jun;203(3):573-82.

PMID:
15573398
5.

Regulation of RANKL-induced osteoclastic differentiation by vascular cells.

Tintut Y, Abedin M, Cho J, Choe A, Lim J, Demer LL.

J Mol Cell Cardiol. 2005 Aug;39(2):389-93.

PMID:
15893766
6.

ADAM gene expression and regulation during human osteoclast formation.

Verrier S, Hogan A, McKie N, Horton M.

Bone. 2004 Jul;35(1):34-46.

PMID:
15207739
8.

A RANKL-inducible gene Znf216 in osteoclast differentiation.

Hishiya A, Ikeda K, Watanabe K.

J Recept Signal Transduct Res. 2005;25(3):199-216.

PMID:
16194934
9.

Current insights into the role of transforming growth factor-beta in bone resorption.

Fox SW, Lovibond AC.

Mol Cell Endocrinol. 2005 Nov 24;243(1-2):19-26. Epub 2005 Oct 10. Review.

PMID:
16219413
10.

Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.

Balga R, Wetterwald A, Portenier J, Dolder S, Mueller C, Hofstetter W.

Bone. 2006 Aug;39(2):325-35. Epub 2006 Mar 31.

PMID:
16580896
11.

Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.

Yang S, Takahashi N, Yamashita T, Sato N, Takahashi M, Mogi M, Uematsu T, Kobayashi Y, Nakamichi Y, Takeda K, Akira S, Takada H, Udagawa N, Furusawa K.

J Immunol. 2005 Aug 1;175(3):1956-64.

12.

Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation.

Iwamoto K, Miyamoto T, Sawatani Y, Hosogane N, Hamaguchi I, Takami M, Nomiyama K, Takagi K, Suda T.

Biochem Biophys Res Commun. 2004 Dec 3;325(1):229-34.

PMID:
15522223
13.
15.

Monokine induced by interferon-gamma is induced by receptor activator of nuclear factor kappa B ligand and is involved in osteoclast adhesion and migration.

Kwak HB, Lee SW, Jin HM, Ha H, Lee SH, Takeshita S, Tanaka S, Kim HM, Kim HH, Lee ZH.

Blood. 2005 Apr 1;105(7):2963-9. Epub 2004 Dec 7.

16.

Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.

Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, Ko JS.

J Periodontal Res. 2006 Aug;41(4):288-96.

PMID:
16827722
17.
18.

Human circulating monocytes can express receptor activator of nuclear factor-kappaB ligand and differentiate into functional osteoclasts without exogenous stimulation.

Seta N, Okazaki Y, Kuwana M.

Immunol Cell Biol. 2008 Jul;86(5):453-9. doi: 10.1038/icb.2008.4. Epub 2008 Feb 26.

PMID:
18301383
19.

Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.

Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N.

Hum Pathol. 2005 Sep;36(9):945-54.

PMID:
16153456
20.

Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.

Kiviranta R, Morko J, Alatalo SL, NicAmhlaoibh R, Risteli J, Laitala-Leinonen T, Vuorio E.

Bone. 2005 Jan;36(1):159-72. Epub 2004 Nov 24.

PMID:
15664014

Supplemental Content

Support Center